Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis

Journal of Hepatology- Netherlands

doi 10.1016/j.jhep.2019.05.014

Full Text

Abstract

Available in

Categories

Hepatology

Date

Authors

Publisher

Elsevier BV

Related search

Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2017English

Sorafenib With Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study

Cancers
Cancer ResearchOncology
2019English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma

Hepatoma Research
2017English

Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2017English

Sorafenib for Advanced Hepatocellular Carcinoma (HCC): Impact of Rationing in the United Kingdom.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Sorafenib Combined With Hepatectomy in Patients With Intermediate-Stage and Advanced Hepatocellular Carcinoma

Archives of Medical Science
Medicine
2017English

Sorafenib Alone Versus Sorafenib Combined With Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses

Radiology
Nuclear MedicineRadiologyImaging
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy